CEL-SCI Corp. (CVM)
1.62
+0.01
(+0.62%)
USD |
NYAM |
Aug 27, 16:00
1.62
0.00 (0.00%)
After-Hours: 16:40
CEL-SCI Total Assets (Quarterly) : 21.36M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 21.36M |
| March 31, 2026 | 17.71M |
| December 31, 2025 | 22.89M |
| September 30, 2025 | 28.16M |
| June 30, 2025 | 20.34M |
| March 31, 2025 | 21.81M |
| December 31, 2024 | 25.70M |
| September 30, 2024 | 26.99M |
| June 30, 2024 | 24.07M |
| March 31, 2024 | 30.05M |
| December 31, 2023 | 28.71M |
| September 30, 2023 | 30.53M |
| June 30, 2023 | 32.32M |
| March 31, 2023 | 38.20M |
| December 31, 2022 | 44.56M |
| September 30, 2022 | 50.52M |
| June 30, 2022 | 56.89M |
| March 31, 2022 | 64.16M |
| December 31, 2021 | 69.67M |
| September 30, 2021 | 75.87M |
| June 30, 2021 | 79.64M |
| March 31, 2021 | 48.37M |
| December 31, 2020 | 49.61M |
| September 30, 2020 | 40.54M |
| June 30, 2020 | 43.91M |
| Date | Value |
|---|---|
| March 31, 2020 | 36.65M |
| December 31, 2019 | 31.49M |
| September 30, 2019 | 27.62M |
| June 30, 2019 | 28.48M |
| March 31, 2019 | 24.76M |
| December 31, 2018 | 25.93M |
| September 30, 2018 | 29.59M |
| June 30, 2018 | 21.70M |
| March 31, 2018 | 23.09M |
| December 31, 2017 | 22.17M |
| September 30, 2017 | 22.92M |
| June 30, 2017 | 21.82M |
| March 31, 2017 | 22.08M |
| December 31, 2016 | 23.25M |
| September 30, 2016 | 24.89M |
| June 30, 2016 | 14.48M |
| March 31, 2016 | 15.52M |
| December 31, 2015 | 19.98M |
| September 30, 2015 | 15.45M |
| June 30, 2015 | 21.50M |
| March 31, 2015 | 12.73M |
| December 31, 2014 | 19.55M |
| September 30, 2014 | 19.23M |
| June 30, 2014 | 25.16M |
| March 31, 2014 | 21.82M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Agenus, Inc. | 172.69M |
| Amgen, Inc. | 95.64B |
| Anika Therapeutics, Inc. | 183.47M |
| BioCryst Pharmaceuticals, Inc. | 557.85M |
| Imunon, Inc. | 14.99M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 10.40M |
| Shareholders Equity (Quarterly) | 10.96M |
| Debt to Equity Ratio | 0.721 |
| Current Ratio | 1.477 |
| Net Debt Paydown Yield | 2.88% |